| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/18/2004 | US20040054163 Isolation method and apparatus |
| 03/18/2004 | US20040054160 Nucleic-acid ink compositions for arraying onto a solid support |
| 03/18/2004 | US20040054158 GL50 molecules and uses therefor |
| 03/18/2004 | US20040054156 Method and reagent for inhibiting hepatitis B viral replication |
| 03/18/2004 | US20040054155 Oligonucleotide compositions with enhanced efficiency |
| 03/18/2004 | US20040054149 Modified proteolytic enzyme for treatment of osteoarthritis |
| 03/18/2004 | US20040054148 Comprises immunoglobulin which preferentially binds aspartate-specific cysteine proteases (ASCPs) for treating and preventing autoimmune, ischemic and neurodegenerative diseases |
| 03/18/2004 | US20040054147 Novel protein, its gene, reagents for inducing apoptosis, and anticancer agent |
| 03/18/2004 | US20040054145 Truncated cd200 |
| 03/18/2004 | US20040054142 Cripto tumour polypeptide |
| 03/18/2004 | US20040054141 Proton-translocating retinal protein |
| 03/18/2004 | US20040054140 Neuronal differentiation regulating factor for treatment of central nervous system disorders |
| 03/18/2004 | US20040054139 Chimeric genetically engineered DNA viral protein for use in immunotherapy and vaccine development |
| 03/18/2004 | US20040054137 Chimeric protein for diagnosis and treatment of cancers and infections; immunotherapy |
| 03/18/2004 | US20040054136 Comprises nucleotide sequences coding transporter associated with antigen processing-like polypeptides (human TAP-like) for diagnosis and treatment of infection, tumors and autoimmune diseases |
| 03/18/2004 | US20040054135 Calcineurin polypeptide for diagnosis and treatment of cardiovascular disorders |
| 03/18/2004 | US20040054134 Hcv ns2/3 fragments and uses thereof |
| 03/18/2004 | US20040054133 Multiple sclerosis-related superantigen |
| 03/18/2004 | US20040054131 Receptor binding amino acid sequences for diagnosis and treatment of tumor and neovascularization disorders |
| 03/18/2004 | US20040053981 Such as 2-(5(6)-nitro-2-benzimidazoyl)-5-(4-nitrophenyl)furan; fluorescent quantitative analysis; for treatment/prevention of cancer |
| 03/18/2004 | US20040053893 Comprises lysophospholipids attached to chromophore; enzyme inhibitors; drug screening; kits |
| 03/18/2004 | US20040053879 Lung resistance protein (LRP/MVP); gene therapy |
| 03/18/2004 | US20040053877 Comprises Sendai virus (SeV) vector; analyzed using LacZ reporter gene and insulin-like growth factor; for treatment of neuromusclar disorders |
| 03/18/2004 | US20040053876 Gene silencing/knockout; hairpin motifs; gene expression inhibition |
| 03/18/2004 | US20040053875 Comprises double-stranded RNA; extracted from HeLa cells |
| 03/18/2004 | US20040053874 Polynucleotide that hybridize with and inhibit gene expression for amphipathic dimeric glycoproteins |
| 03/18/2004 | US20040053873 Electroporation methods for introducing bioactive agents into cells |
| 03/18/2004 | US20040053872 Administering polynucletides that inhibit interactions polymerases with tRNA, to humans for prophylaxis of aquired immune deficiency syndrome |
| 03/18/2004 | US20040053870 CpG reduced plasmids and viral vectors |
| 03/18/2004 | US20040053869 Stem cell differentiation |
| 03/18/2004 | US20040053868 Administering polynucleotides, BCL genes or proteins, fusion proteins and/or carrier mixtures, as antiapoptotic agents |
| 03/18/2004 | US20040053867 Nucleotide sequences that code for transport proteins; modulation of excitatory amino acids or signal tranduction; detoxification |
| 03/18/2004 | US20040053863 Sensitization of HER-2/neu overexpressing cancer cells to chemotherapy |
| 03/18/2004 | US20040053845 Modified peptides as therapeutic agents |
| 03/18/2004 | US20040053843 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
| 03/18/2004 | US20040053835 Reagents which regulate and bind to human NMDA receptor gene products can play role in preventing, ameliorating, or correcting dysfunctions or diseases including asthma, genito-urinary system disorders |
| 03/18/2004 | US20040053833 Relates to regulation of activity of NET (ERP/SAP-2) protein and to compounds which modify or regulate NET protein activity; methods of screening for agonists or antagonists of NET in order to identify new pro- or anti-angiogenic compounds |
| 03/18/2004 | US20040053831 Veterinary immunisation vectors |
| 03/18/2004 | US20040053829 Polypeptide having preferably antitumoral and/or immunomodulating cytokine properties, which can be activated by processing in vivo comprising a central region with specific biological activity |
| 03/18/2004 | US20040053827 Novel polypeptide human polyadenylation binding protein 20.13 and polynucleotide encoding it |
| 03/18/2004 | US20040053826 Uses of polypeptides |
| 03/18/2004 | US20040053816 Adipocyte culture-cells from fat tissue, liver and kidney from the carp |
| 03/18/2004 | US20040053812 Methods |
| 03/18/2004 | US20040053413 Escherichia mutant lacking endogenous plasmids for use as gene propagation and genetic engineering tools |
| 03/18/2004 | US20040053412 Cells resistant to toxic genes and uses thereof |
| 03/18/2004 | US20040053411 Using plasmids coding and expressing hairpin loop structures to transform cells and control transcription activity |
| 03/18/2004 | US20040053410 Method for introducing a nucleic acid into a cell (transfection) by means of calcium phosphate and transfected cell |
| 03/18/2004 | US20040053405 Matrix reactor and a method for producing products in said reactor |
| 03/18/2004 | US20040053397 Comprises sodium glucose transport proteins for treating diabetes and hyperlipidemia; drug screening |
| 03/18/2004 | US20040053393 Comprises genetically engineered bacteriophage polymerase for detection and treatment of microorganismal infections |
| 03/18/2004 | US20040053390 Generating mutant aminoacyl transfer RNA synthetase for de novo design of artificial proteins |
| 03/18/2004 | US20040053387 Comprises nucleotide sequences coding pholem immobilized transferase fused to insecticidal proteins for generating disease resistant plants |
| 03/18/2004 | US20040053386 Terpene synthase having a region with 20% or greater sequence identity to specific residues of perferential amino acid sequence, and such synthase containing nine alpha-carbon having interatomic distance +-2.3 Angstroms between alpha C |
| 03/18/2004 | US20040053382 Oxidizing an alpha-amino-carboxylic acid, hydrate, or salt thereof using a L-amino acid deaminase or oxidase and subsequently reducing the product thereof using a dehydrogenase |
| 03/18/2004 | US20040053379 Method of producing polyunsaturated fatty acids, novel biosynthesis genes, and novel plant expression constructs |
| 03/18/2004 | US20040053370 Comprises chimeric glucagon-like peptides-1 (GLP-1) for treating obesity and non-insulin dependent diabetes mellitus |
| 03/18/2004 | US20040053368 Collagen-binding hybrid polypeptide |
| 03/18/2004 | US20040053366 Comprises nucleotide sequences coding leptin chimeric polypeptide for treatment and prevention of weight and cardiovascular disorders |
| 03/18/2004 | US20040053364 Genetically engineered immunoglobulin receptor for modulating humoral response in transplant patients |
| 03/18/2004 | US20040053363 Preparing multicompoment polypeptide for treating cancer and infections; immunotherapy |
| 03/18/2004 | US20040053362 Preparing fusion protein comprising multiple functional protein domains via homologous recombination |
| 03/18/2004 | US20040053361 Nucleic acid construct useful for expressing transgenes in particular in embryonic stem cells |
| 03/18/2004 | US20040053360 Preparing proteolytic polypeptide comprising amino acid attachment at carboxy-terminal for reducing odors generated when washing textiles solied with milk fat |
| 03/18/2004 | US20040053359 Preparing multicompoment polypeptide for treating cancer and infections; immunotherapy |
| 03/18/2004 | US20040053358 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/18/2004 | US20040053357 Nucleic acid encoding kv10.1 a voltage-gated potassium channel from human brain |
| 03/18/2004 | US20040053354 Methods for optically immobilizing very small objects and their use |
| 03/18/2004 | US20040053345 Monitoring and prognosing effectivness of antitumor agents via presence or absence of tumor activator protein menin |
| 03/18/2004 | US20040053344 Using human leukocyte antigen protein-f to classify and identify cell proliferative disorders |
| 03/18/2004 | US20040053332 Compositions and methods for detecting proteolytic activity |
| 03/18/2004 | US20040053329 Endoglin-specific polypeptide, production and use thereof |
| 03/18/2004 | US20040053325 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine -1 (mic-1) |
| 03/18/2004 | US20040053320 Hybridization probes derived from the spacer region between the 16S and 23S rRNA genes for the detection of non-viral microorganisms |
| 03/18/2004 | US20040053319 Liquefying complex biological constructs, extracting RNA and monitoring gene expression |
| 03/18/2004 | US20040053318 Preservation of RNA and reverse transcriptase during automated liquid handling |
| 03/18/2004 | US20040053314 ADAM20 (SVPH1-26) DNA and polypeptides |
| 03/18/2004 | US20040053310 Using high throughput assays to identify RNA ligands; drug screening and rational drug design |
| 03/18/2004 | US20040053305 Substrate processing method and method for manufacturing probe carrier |
| 03/18/2004 | US20040053304 Methods and compositions for detecting cancers |
| 03/18/2004 | US20040053303 Comprises ubiquitin ligase for controlling/modulating weight gain and loss |
| 03/18/2004 | US20040053300 Method and test kit for quantitative determination of variations in polynucleotide amounts in cell or tissue samples |
| 03/18/2004 | US20040053299 Regulated activation of cell-membrane receptors by metal-chelating agonists |
| 03/18/2004 | US20040053297 Cytokine-like proteins |
| 03/18/2004 | US20040053296 Method for localizing polypeptide on cell surface |
| 03/18/2004 | US20040053293 Novel core 2 beta-1,6-N-acetylglycosaminyltransferase gene |
| 03/18/2004 | US20040053292 Comprises nucleotide sequences coding polypeptide containing signal peptide sequences for treatment and prevention of psoriasis, asthma, artheriosclerosis, infections, meningitis, pneumonia and multiple sclerosis |
| 03/18/2004 | US20040053289 Comprises oligonucleotide sequences for us as antitumor agents, viricides, fungicides, herbicides and/or pesticides |
| 03/18/2004 | US20040053288 Method for estimating therapeutic efficacy of tumor necrosis factor |
| 03/18/2004 | US20040053285 Plant transcription factors |
| 03/18/2004 | US20040053284 Universal multi-variant detection system |
| 03/18/2004 | US20040053283 Gene 4 |
| 03/18/2004 | US20040053281 Comprises enzymatic polypeptide associated with fatty acid metabolism for diagnosing, treating and preventing cancer, neurodegenerative, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders |
| 03/18/2004 | US20040053280 Method for selecting nucleic acids that bond with high-affinity to a target |
| 03/18/2004 | US20040053279 Thermostable polymerases from thermococcus pacificus |
| 03/18/2004 | US20040053278 Smad6 and uses thereof |
| 03/18/2004 | US20040053276 Comprises protein factors for diagnosis, prevention and treatment of cancers, infections, immunological, gastrointestinal, organ and endocrine disorders; animal models for disease |
| 03/18/2004 | US20040053274 Gene cluster of vicenistatin biosynthesis, a vicenisamine glycosyltransferase polypeptide, and a gene encoding the polypeptide |
| 03/18/2004 | US20040053273 Comprises expression vector coding nitrilase transcription regulatory protein and promoter for transformation and expression of heterologous protein in streptomyces |
| 03/18/2004 | US20040053272 Methods of constructing a model of cellular development and differentiation using homozygous stem cell systems, methods of assessing and cataloging proteins expressed therein, cDNA libraries generated therefrom, and materials and methods using same |
| 03/18/2004 | US20040053271 2'-fluoropyrimidine anti-calf intestinal phosphatase nucleic acid ligands |